Back
ANI Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison
Sell
31
ANIP
ANI Pharmaceuticals
Last Price:
$54.23
Seasonality Move:
15.88%
Sell
41
NBIS
Nebius Group NV
Last Price:
$28.24
Seasonality Move:
-4.07%
Sell
31
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
-
The current ANI Pharmaceuticals [ANIP] share price is $54.16. The Score for ANIP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
ANIP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $28.25. The Score for NBIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $54.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $28.25The current trend is moderately bullish and NBIS is experiencing slight buying pressure.
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 40.22 | Sell |
Chaikin Money Flow: | 28908 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.83 - 58.19) | Sell |
Bollinger Bands (100): | (56.14 - 60.88) | Sell |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.41 | Buy |
Relative Strength Index (14 RSI): | 52.29 | Buy |
Chaikin Money Flow: | 299015 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.06 - 32.3) | Buy |
Bollinger Bands (100): | (16.89 - 25.75) | Buy |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.84 | Sell |
20-day SMA: | 56.53 | Sell |
50-day SMA: | 57.64 | Sell |
200-day SMA: | 61.71 | Sell |
8-day EMA: | 54.83 | Sell |
20-day EMA: | 56.01 | Sell |
50-day EMA: | 57.24 | Sell |
200-day EMA: | 59.08 | Sell |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.9 | Sell |
20-day SMA: | 29.09 | Sell |
50-day SMA: | 23.69 | Buy |
200-day SMA: | 20.13 | Buy |
8-day EMA: | 28.69 | Sell |
20-day EMA: | 28.11 | Buy |
50-day EMA: | 25.05 | Buy |
200-day EMA: | 21.08 | Buy |
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.45 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ANI Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |